← All trials
NCT06710132
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 15, 2025
- Primary completion
- Jan 31, 2029
- Completion date
- Jan 31, 2029
- First posted
- Nov 29, 2024
- Last posted
- Nov 29, 2024
- Enrollment
- 250
- Arms / groups
- 5 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Merck SeronoLead sponsor
- Merck KGaACollaborator
- Merck KGaACollaborator
- Merck KGaAOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.